Cyclosporine OphthalmicCyclosporine

About Cyclosporine Ophthalmic

Cyclosporine is a calcineurin inhibitor immunosuppressant; on the eye it damps the inflammation that holds back tear production in keratoconjunctivitis sicca (dry eye). Restasis and its generics (0.05 percent emulsion) are approved to increase tear production when it is presumed suppressed by ocular inflammation, and are not established under age 16. Cequa (0.09 percent solution) is approved to increase tear production in dry eye, and Vevye (0.1 percent solution in a water-free vehicle) for the signs and symptoms of dry eye disease; neither is established under 18. All three are one drop in each eye twice a day, about 12 hours apart. Verkazia (0.1 percent emulsion) treats vernal keratoconjunctivitis, a severe allergic eye condition, in children and adults, as one drop in each affected eye four times a day.

There is no boxed warning. The labels carry two cautions: do not let the vial or bottle tip touch the eye or any surface, which can injure the eye or contaminate the drops, and do not put the drops in while wearing contact lenses; lenses come out first and go back in 15 minutes later. Restasis is contraindicated with a known or suspected allergy to any ingredient; the other three labels list no contraindications. The most common side effects are burning, stinging or pain when the drop goes in, redness of the eye, and (with Vevye) a temporary drop in sharpness of vision. Hives, swelling of the face or throat, or shortness of breath need urgent care.

The emulsions (Restasis, its generics and Verkazia) look milky and are turned over or shaken gently before use; Cequa and Vevye are solutions. Most products are preservative-free single-use vials discarded after one use, and the labels require the whole tray or box to be dispensed intact. Restasis MultiDose and Vevye come in bottles that, once opened, can be used until the printed expiration date. The Restasis and Vevye labels report undetectable blood levels after the drops, and Restasis states that fetal exposure is not expected; the Cequa label reports low levels, the Verkazia label reports low but sometimes measurable levels, and both say there are no adequate studies in pregnancy. Verkazia is established for ages 4 through 18. None of the labels has studied passage into breast milk after use in the eye, so discuss breastfeeding with the prescriber.

Taking Cyclosporine Ophthalmic

How to take it

Wash your hands, and turn an emulsion vial or bottle over a few times until it looks uniformly white. Put one drop in each eye twice a day, about 12 hours apart (Verkazia: four times a day), without letting the tip touch your eye, then discard a single-use vial even if liquid is left. Take contact lenses out first and put them back 15 minutes later.

If you miss a dose

Use it when you remember, unless it is almost time for the next dose; then skip the missed dose and carry on. Do not use a double dose.

Storage

At room temperature, away from heat and moisture, out of reach of children; do not freeze, and keep unopened vials in their foil pouch. Return unwanted drops through a take-back program rather than flushing them.

Interactions to know about

Very little reaches the bloodstream from the eye drops, so the practical interaction is timing: other eye drops, including artificial tears, go in at least 15 minutes apart (10 minutes for Verkazia). Tell the prescriber about any allergy to cyclosporine in any form, including the oral capsules Gengraf, Neoral and Sandimmune.

This summarizes the official prescribing information. Your prescriber’s and pharmacist’s instructions, and the leaflet that comes with your medicine, take priority.

Why the cash price for Cyclosporine Ophthalmic differs from pharmacy to pharmacy

The 0.05 percent vials are the one form with competition: several generic makers have entered since 2022, with more approved in 2025 and 2026, so a pharmacy that fills them often can quote far less than one that orders a tray in for a single prescription. A prescription that names Restasis or blocks substitution is filled at the brand price, and because a full tray of 30 or 60 vials must be dispensed, the count on the prescription decides how many trays are needed.

Cequa, Vevye, Verkazia and Restasis MultiDose have no generic, so their quotes reflect the brand cost plus the pharmacy’s fee, and they are not stocked everywhere. None is rated equivalent to another or to Restasis, so a pharmacist cannot swap one for another at the counter; changing products needs a new prescription.

Ways to pay less for Cyclosporine Ophthalmic without insurance

• If the prescription is for Restasis 0.05 percent vials, ask for generic substitution; the generics are rated equivalent.
• If you were prescribed Cequa, Vevye or Restasis MultiDose, ask the prescriber whether the generic 0.05 percent emulsion would suit you.
• Once you are settled on the drops, ask whether a ninety-day supply is possible, so you pay fewer dispensing fees.
• For a brand-only product, ask the maker whether its savings or patient assistance program applies to someone paying cash.
• Upload the prescription to Script Unlock so licensed pharmacies can quote their cash price. You pay the pharmacy directly.

Questions to ask your pharmacist about Cyclosporine Ophthalmic

1. 1.Is the generic you stock rated equivalent to my Restasis prescription?
2. 2.How long should I wait between my cyclosporine drops and my other eye drops?
3. 3.Can I keep using my opened Restasis MultiDose or Vevye bottle until its expiration date?
4. 4.My drops burn when I put them in; is that expected, and when should I call my eye doctor?

Related medications